Publications by authors named "Helene Labussiere"

Claim this Profile
O
Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (GFM-DACORAL-DLI): a multicentre, single-arm, phase 2 trial.
Marie Robin, Maud D'Aveni, Aspasia Stamatoullas, Emmanuel Raffoux, Patrice Chevallier

Lancet Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib stopped before transplantation does not induce cytokine release in myelofibrosis.
Sara Villar, Emmanuel Curis, Marie-Hélène Schlageter, Nelly Bosselut, Amandine Charbonnier

Cancer Immunol Immunother· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second line extracorporeal photopheresis for cortico-resistant acute and chronic GVHD after allogeneic hematopoietic cell transplantation for hematological malignancies: Long-term results from a real-life study.
Mauricette Michallet, Mohamad Sobh, Alexandre Deloire, Daniela Revesz, Youcef Chelgoum, Helene Labussiere

Transfus Apher Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial.
Eolia Brissot, Myriam Labopin, Helene Labussière, Gaelle Fossard, Patrice Chevallier

Blood Cancer J· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sickle cell disease and acute leukemia: one case report and an extensive review.
Giovanna Cannas, Solène Poutrel, Maël Heiblig, Hélène Labussière, Marie-Virginie Larcher

Ann Hematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC.
Paul Chauvet, Annalisa Paviglianiti, Myriam Labopin, Hélène Labussière, Nicolas Boissel

Bone Marrow Transplant· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual disease including AML leukemia stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometry.
Adriana Plesa, Christophe Roumier, Joris Gutrin, Marie-Virginie Larcher, Marie Balsat

Leuk Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study.
David Beauvais, Elodie Drumez, Didier Blaise, Régis Peffault de Latour, Edouard Forcade

Bone Marrow Transplant· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party.
Abdul Hamid Bazarbachi, Rama Al Hamed, Myriam Labopin, Kazimierz Halaburda, Helene Labussiere

Bone Marrow Transplant· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current IST-free/relapse-free survival as a new endpoint after allogeneic hematopoietic stem cell transplantation.
Roberto Crocchiolo, Alessio Signori, Mohamad Sobh, Helene Labussiere, Myriam Renault

Ann Hematol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lyon-University Hospital Experience with Gemtuzumab Ozogamicin Therapy in Acute Myeloid Leukemia: a 'Real-Life' Study.
Marica Laurino, Sandrine Loron, Marie-Virginie Larcher, Gaëlle Fossard, Mohamed Elhamri

Mediterr J Hematol Infect Dis· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC).
Amandine Fayard, Elisabeth Daguenet, Didier Blaise, Patrice Chevallier, Hélène Labussière

Bone Marrow Transplant· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elderly Patients (Age 70 Years or Older) With Secondary Acute Myeloid Leukemia or Acute Myeloid Leukemia Developed Concurrently to Another Malignant Disease.
Elodie Collinge, Sandrine Loron, Marie-Virginie Larcher, Mohamed Elhamri, Maël Heiblig

Clin Lymphoma Myeloma Leuk· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical Trial.
Frédéric Garban, Audrey Guyard, Helene Labussière, Claude-Eric Bulabois, Tony Marchand

JAMA Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience.
Maël Heiblig, Caroline Le Jeune, Mohamed Elhamri, Marie Balsat, Isabelle Tigaud

Leuk Lymphoma· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential anti-leukemic activity of iron chelation after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia.
Mauricette Michallet, Mohamad Sobh, Hélène Labussière, Christine Lombard, Fiorenza Barraco

Leuk Lymphoma· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using EasyMatch® to anticipate the identification of an HLA identical unrelated donor: A validated efficient time and cost saving method.
Valérie Dubois, Marie Detrait, Mohamad Sobh, Stéphane Morisset, Hélène Labussière

Hum Immunol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) with Acute Myeloid Leukemia: A Single Institution Experience.
Maël Heiblig, Mohamed Elhamri, Isabelle Tigaud, Adriana Plesa, Fiorenza Barraco

Mediterr J Hematol Infect Dis· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute graft-versus-host disease, invasive aspergillosis and Clostridium difficile colitis after peripheral blood stem cell transplantation: A complex network of causalities and a challenge for prevention.
Nagham Khanafer, Antoine Neuraz, Thomas Bénet, Martin Cour, Florence Persat

Anaerobe· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic stem cell transplant for hematological malignancies from mismatched 9/10 human leukocyte antigen unrelated donors: comparison with transplants from 10/10 unrelated donors and human leukocyte antigen identical siblings.
Mauricette Michallet, Mohamad Sobh, Caroline Serrier, Stéphane Morisset, Hélène Labussière

Leuk Lymphoma· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving strategies with immunomodulating drugs and tandem autologous/allogeneic hematopoietic stem cell transplantation in first line high risk multiple myeloma patients.
Mauricette Michallet, Mohamad Sobh, Jean El-Cheikh, Stéphane Morisset, Anne Sirvent

Exp Hematol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis.
Franck E Nicolini, Amr R Ibrahim, Simona Soverini, Giovanni Martinelli, Martin C Müller

Haematologica· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobilization of CD34(+)CD38(-) hematopoietic stem cells after priming in acute myeloid leukemia.
Adriana Plesa, Youcef Chelghoum, Eve Mattei, Hélène Labussière, Mohamed Elhamri

World J Stem Cells· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients.
Mauricette Michallet, Karine Goldet, Mohamad Sobh, Stéphane Morisset, Youcef Chelghoum

Cancer· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens.
Marie Detrait, Valérie Dubois, Mohamad Sobh, Stéphane Morisset, Nathalie Tedone

Exp Hematol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis